Drug infusion systems market seen reaching $22.23 billion by 2030

The Business Research Company says the drug infusion systems market will rise from $14.23 billion in 2025 to $15.51 billion in 2026, then reach $22.23 billion by 2030. Growth is tied to rising healthcare spending, more chronic disease treatment, and wider use of smart and connected infusion devices.

Why it matters: - Drug infusion systems are central to delivering medications and fluids in hospitals, clinics and homecare settings. - The market’s growth signals more demand for precise drug delivery, automation and patient-safety features in healthcare. - Rising healthcare spending is giving medical institutions more room to buy advanced infusion technology.

What happened: - The Business Research Company published a drug infusion systems market report on Aug. 5, 2026. - The report says the market will grow from $14.23 billion in 2025 to $15.51 billion in 2026. - The report projects the market will reach $22.23 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region during the forecast period.

The details: - The report links near-term growth to rising hospitalization rates, more chronic illnesses, oncology and chemotherapy treatment growth, broader use of intravenous drug delivery and better access to infusion technology. - The report ties longer-term growth to connected infusion devices, ambulatory and homecare infusion demand, precision drug delivery advances, automated hospital workflows and investment in smart healthcare infrastructure. - Key trends identified include wider adoption of smart infusion pumps, deeper integration of dose error reduction systems, more multi-channel infusion devices, expansion of home-based infusion therapies and stronger patient-safety features. - Drug infusion systems deliver medications and fluids through catheters or needles. - The systems are used to administer pain management drugs, antibiotics, chemotherapy agents and hydration fluids. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company added market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables to its 2026 reports. - The report offers a free sample at Download a free sample of the market report. - The full report is available at View the full market report.

Between the lines: - The forecast points to a market moving from basic infusion hardware toward connected, automated systems. - Home-based infusion therapies and ambulatory care appear to be becoming a bigger part of the market mix. - The ONS said total UK healthcare spending rose 5.6% in nominal terms from 2022 to 2023, compared with 0.9% growth in the prior year. - That spending trend suggests hospitals and health systems may keep upgrading infusion equipment as budgets expand.

What's next: - The market is expected to keep expanding through 2030 if healthcare spending and demand for chronic disease treatment continue to rise. - Smart pumps, dose error reduction systems and other patient-safety features are likely to shape product development. - Asia-Pacific’s growth trajectory could make the region a bigger focus for manufacturers and suppliers.

The bottom line: - Drug infusion systems are moving from a steady-growth category to a higher-tech care platform, with smart and connected devices doing most of the heavy lifting.